Lung Cancer in the U.S.: Trends and Prevention
美国肺癌:趋势与预防
基本信息
- 批准号:7290000
- 负责人:
- 金额:$ 7.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-10 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:age differencecancer preventioncarcinogenesisclinical researchcooperative studygender differencehuman datalung neoplasmsneoplasm /cancer epidemiologyneoplasm /cancer typeneoplastic processneoplastic transformationracial /ethnic differencestatistics /biometrysubstance abuse epidemiologysubstance abuse related behaviortobacco abuse
项目摘要
DESCRIPTION (provided by applicant):
Under the auspices of our currently funded CISNET grant we have been developing models based on ideas of multistage carcinogenesis for prediction of lung cancer incidence and mortality rates. In this renewal CISNET application we propose to use these models to predict lung cancer risk in the US under diverse smoking scenarios. We will also develop user-friendly software to implement our models. This software will be made freely available to interested scientists. Our models can explicitly accommodate detailed smoking histories on individuals including age at initiation, number of cigarettes smoked per day, changes in levels of smoking, and age at quitting if an ex-smoker. Moreover the models can be used to predict risks both in individuals and populations. Thus the models can be used to predict both individual and population risks under various intervention scenarios for smoking cessation. Since the models are based on the biological paradigm of initiation, promotion and progression in carcinogenesis, they can be used to generate biological hypotheses regarding the mechanism of tobacco induced lung cancer and to explore the extent to which projected risks depend on specific mechanistic aspects of smoking-induced lung cancer. We propose to explore collaboration with other investigators supported by CISNET, particularly those interested in using our model as the 'natural history' component of screening models.
描述(由申请人提供):
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SURESH H MOOLGAVKAR其他文献
SURESH H MOOLGAVKAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SURESH H MOOLGAVKAR', 18)}}的其他基金
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6592904 - 财政年份:2002
- 资助金额:
$ 7.99万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6545083 - 财政年份:2002
- 资助金额:
$ 7.99万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6799971 - 财政年份:2002
- 资助金额:
$ 7.99万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6950039 - 财政年份:2002
- 资助金额:
$ 7.99万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6656866 - 财政年份:2002
- 资助金额:
$ 7.99万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6751851 - 财政年份:2002
- 资助金额:
$ 7.99万 - 项目类别:
相似海外基金
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10829054 - 财政年份:2023
- 资助金额:
$ 7.99万 - 项目类别:
Bacteria-derived xenobiotics in colon cancer prevention: Link to GPR109A and colonic ketogenesis
细菌源性异生素在结肠癌预防中的作用:与 GPR109A 和结肠生酮的联系
- 批准号:
10737017 - 财政年份:2023
- 资助金额:
$ 7.99万 - 项目类别:
Colon cancer prevention with non-systemic PDE5 inhibitors
使用非全身性 PDE5 抑制剂预防结肠癌
- 批准号:
10484106 - 财政年份:2022
- 资助金额:
$ 7.99万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA)
在乌干达实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (CASCADE UGANDA)
- 批准号:
10544355 - 财政年份:2022
- 资助金额:
$ 7.99万 - 项目类别:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
- 批准号:
10512091 - 财政年份:2022
- 资助金额:
$ 7.99万 - 项目类别:
Gene-tobacco carcinogen interactions and lung cancer risk - a novel approach for precision cancer prevention
基因-烟草致癌物相互作用和肺癌风险——精准癌症预防的新方法
- 批准号:
10581340 - 财政年份:2022
- 资助金额:
$ 7.99万 - 项目类别:
Quantifying NNK metabolites to facilitate Kava lung cancer prevention clinical translation
量化 NNK 代谢物以促进 Kava 肺癌预防临床转化
- 批准号:
10683294 - 财政年份:2022
- 资助金额:
$ 7.99万 - 项目类别:
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Uganda (CASCADE UGANDA)
在乌干达实施艾滋病毒/宫颈癌预防 CASCADE 临床试验 (CASCADE UGANDA)
- 批准号:
10700084 - 财政年份:2022
- 资助金额:
$ 7.99万 - 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10563186 - 财政年份:2021
- 资助金额:
$ 7.99万 - 项目类别:
Advancing skin cancer prevention by tackling UV-induced clonogenic mutations
通过应对紫外线诱导的克隆突变来促进皮肤癌的预防
- 批准号:
10339333 - 财政年份:2021
- 资助金额:
$ 7.99万 - 项目类别: